ArticleNeuro-oncology advances

Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in

Srirupa Bhattacharyya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.